MRNA is doing splendidly for me even though is up 1%,
I have rolled up Jan15 $120 to Jan22 $125 and Jan29 $130 to exploit the rally.
1 Like
Run an errand and back. Wow!
Look like your algo and FA are pretty good 
Now regretting not pumping more money IN.
1 Like
Third time is real?
2 Likes
1 Like
But I have way AAPL than you have in MRNA?
Do not you want to beat WQJ? Buy BNGO…
.
Sure you know what you are talking?
1 Like
Goodbye all genomics stocks, MRNA and BNTX?
After watching some videos on NNDM and BNGO, realize is of same category as LQMT. LQMT was hyped to $20+ 
, now is trading at 11 cents 
I mean as super risky as LQMT. Well Cathie bought big into NNDM. She didn’t buy BNGO (yet?).
REGN and TDOC on 
MRNA 
1 Like
Yelled will send Bitcoin back the toilet it came from. Down 20%
I invested $100k in REGN, buy n hold (hopefully for about 10 years). I like it because of the EW picture. Refer to the chart of REGN, only show Primary and Cycle degree because is a multi-year investment. Wave V should last 2-10 years with an extended 3rd wave which I believe has just started. I am considering buying LEAPs calls to capitalize on the powerful 3rd wave, Primary degree wave 3. However, as a slow 
decision maker, has not decided which strike price.
1 Like
Have you seen RSI at 66? for B&H, it does not matter, but options, time bound, it matters. You may need to wait until it reaches some bottom.
For that matter CRSP is at it possible lower price, but not so much interested in CRSP.
BTW: My biotechs are over with MRNA and BNTX, no further BIO-tech.
1 Like
Agree.
Didn’t do a detailed EWA but looking at the daily chart casually, two bearish issues:
a. Bearish divergence
b. Might have completed a wave 5 (or wave v) so could possibly in some kind of wave two (generic label), a down wave lasting a few months.
Decision: Avoid for now.
I spread the risk. $100k in REGN, $50k in MRNA and $50k in TDOC. BNTX and MRNA have the same risk since same class of drug.
1 Like
For CRSP, more than EWT, you need fundamental study…read the status of their gene editing technology.
REGN is 57B company while CRSP is 14B, lot of room to grow. Company is small, can grow easily if they succeed in single breakthrough !
4x is not a big difference. CRSP market cap might be a little over-inflated because of the “new toilet effect” of CRSPR gene editing technique… ditto for mRNA. Vaguely (may not have understood well) read that there are competing solution… I need to read up a lot more, a lot to read 
I am in a act first think later mood… buy first read later
1 Like
Nearly all biotech stocks shot up today.
I missed TWST somehow yesterday. Still need to do research on that company.
Since spy and Nasdaq are positive, every company shoots up with index
1 Like